An animal drug application or
supplemental animal drug application submitted by a person subject
to application fees is considered incomplete and will not be
accepted for filing by FDA until all fees owed by such person have
been paid. Section 740(e) of the FD&C Act. ADUFA requires the
submisssion of the User Fees concurrently with applications. If the
required fees are not submitted, the review of the application will
not begin. The User Fee Cover Sheet provides the information
necessary to either initiate or defer the application
review.
Johnny Vilela 301 796-3792
juanmanuel.vilela@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.